All News

OVER THE LAST FEW years, significant advances were made in the treatment of patients with chronic lymphocytic leukemia (CLL). Several novel therapies, most of them oral, have now been approved by the Food and Drug Administration. These include Imbruvica (ibrutinib), a Bruton’s tyrosine kinase (BTK) inhibitor; Venclexta (venetoclax), a B-cell lymphoma-2 (BCL2) inhibitor; and Zydelig (idelalisib), a phosphoinositide 3-kinase (PI3K) inhibitor.

Opdivo (nivolumab) was granted FDA approval for the treatment of hepatocellular carcinoma (HCC) – regardless of PD-L1 status – for patients who have previously been treated with Nexavar (sorafenib).

Venclexta (venetoclax), a BCL-2 inhibitor, had promising results in patients with relapsed or refractory chronic lymphocytic leukemia (CLL). According to an updated analysis of a clinical trial, the agent led to negative minimal residual disease (MRD) in 40 percent of patients involved.

Breast cancer survivor reflects back on what she wishes the medical profession's approach could have been to her cancers.

Living in a selfie-centered world can be challenging, especially for those touched by breast cancer.

Pink ribbons came out of the woodwork when I was diagnosed with breast cancer, and at first, I hated them.

I was diagnosed with cancer, quit my job, put college on hold, started chemo, didn't get a role in "Saving Private Ryan" and started digging in the dirt.

Two-time cancer survivor says lets look death and dying in the face so we don't live our lives in (as much) fear.

Immunotherapy agents are promising in the treatment of cancer, but also come with some awful side effects.

The ratio of neutrophils to lymphocytes – two types of white blood cells – can give oncologists valuable information regarding a patient’s prognosis.

It is important to consider quality of life and survival calculations when treating older patients with HER2-positive or triple-negative breast cancer (TNBC), according to a recent talk at the 2017 Lynn Sage Breast Cancer Symposium.

Life after cancer has its own physical and emotional challenges.

Nature has provided medicine for many ailments. A male breast cancer survivor asks, why not this one?

How one cancer survivor attempts to cope with the reality of having chemo for the rest of her life.

In a recent phase 2 study, nearly half of patients who had resectable stage 3B/C BRAF V600-mutant melanoma achieved pathologic complete response (pCR) – meaning that no active cancer cells are present – with neoadjuvant combination therapy consisting of Tafinlar (dabrafenib) and Mekinist (trametinib).

Genomic testing is often expensive and inaccessible to those who can't afford the costs, but companies are working diligently to provide people with alternatives.

Blogging for CURE helped me find my voice and process my breast cancer experience.

From fatigue to chemo brain, Curetoday.com and CURE Magazine offer a variety of resources for people dealing with these effects.

Brian d'Arcy James of 13 Reasons Why, Spotlight, and Hamilton is set to take on the 2017 Bank of America Chicago Marathon and raise money to support cancer patients and their loved ones served by the Cancer Support Community.

In early 2015, Zika outbreaks caused widespread panic in many parts of North and South America. However, now researchers are exploring the possibility of putting the virus to good use: fighting glioblastoma multiforme (GBM), the most deadly type of brain cancer.

How a fake Buddha quote changed my life.

At one time, the word “cancer” was only whispered and never spoken out loud. Times change, but sometimes it’s hard to let those you work with know that you have/had cancer.

Jevtana (cabazitaxel) was granted approval by the Food and Drug Administration (FDA) for the treatment of men with metastatic castration-resistant prostate cancer who previously received a docetaxel-containing regimen.

People used to think that palliative care and hospice were one in the same. However, now it has a separate category of its own.

Martha Carlson talks about what it's like to join a group of active advocates for stage 4 breast cancer

An optimistic attitude is beneficial to achieving good health. Those affected by cancer need to learn to tap into the valuable resource of positive self-talk. Here's how:

Chemo brain affects each of us in different ways. Using our brains to negotiate a relationship with it is, ironically, the best way to forge ahead without despairing.

An injured cancer survivor reluctantly but gratefully copes with neuropathy, osteopenia and stiff-joint cancer side effects after recently breaking her foot and getting surgery.

The Food and Drug Administration approved the first ever biosimilar to treat a variety of cancers.

David S. Siegel, M.D., Ph.D., chief of the division of Multiple Myeloma at the John Theurer Cancer Center, attributes some of the progress in myeloma treatment to patients and how they advocate for themselves.